Welcome to our dedicated page for PHARM-BIO SERV news (Ticker: PBSV), a resource for investors and traders seeking the latest updates and insights on PHARM-BIO SERV stock.
PHARM-BIO SERV INC (PBSV) is a leading player in the life sciences industry, specializing in regulatory compliance, validation, and support services for regulated industries. Established in February 1993, PHARM-BIO SERV offers technical services, product and process transfers, commissioning, process engineering, and technology transfer to a variety of industries including pharmaceutical, medical devices, consumer, chemical, and biotechnology sectors in Puerto Rico, the United States, Brazil, and Europe. The company's integrated service structure is designed to provide comprehensive solutions to meet client needs. PHARM-BIO SERV has diversified its services by introducing new divisions to support clients, such as ScienzaLabs, a laboratory testing facility in Puerto Rico and Spain providing microbiological and analytical testing services; Metrologix, offering calibration program management solutions; and Integratek, providing IT services.
Pharma-Bio Serv (OTCQB:PBSV), a consulting firm for pharmaceutical and related industries, reported financial results for Q3 2024. The company experienced a significant decline in revenues and profitability. Revenues for the three and nine months ended July 31, 2024, were $2.4 million and $7.2 million respectively, representing decreases of $2.2 million and $6.2 million compared to the same periods last year. The company reported net losses of $0.3 million and $0.8 million for the three and nine-month periods, contrasting with net incomes of $0.5 million and $1.4 million in the previous year. CEO Mr. Sanchez acknowledged industry challenges but highlighted investments in technological tools to identify global business opportunities, aiming to restore profitability and revenue growth.
Pharma-Bio Serv (OTCQB:PBSV), a consulting firm serving various industries including pharmaceuticals, announced a revenue decline for the three and six months ending April 30, 2024. Revenues were $2.4 million and $4.8 million, respectively, marking a decrease of $2.2 million and $4.0 million compared to the same periods last year. The company reported a net loss of $0.2 million and $0.5 million for these periods, compared to net income of $0.4 million and $0.8 million in the previous year. Despite these setbacks, the company is investing in new client relationships and global events to foster growth and stability in the future.
Pharma-Bio Serv, Inc. (OTCQB:PBSV) reported revenue of approximately $4.2 million for the quarter ending January 31, 2023, marking a decrease of $0.8 million year-over-year. However, net income rose to $0.4 million, an increase of $0.1 million compared to the previous year. The CEO, Mr. Sanchez, emphasized the strategic focus on more profitable markets, resulting in improved gross profit percentages. The company operates in markets including Puerto Rico, the US, Europe, and Latin America, providing regulatory compliance consulting services across various industries.
Pharma-Bio Serv (OTCQB:PBSV) has announced a Special Dividend of $0.075 per share, payable on or about April 14, 2023. This dividend is for shareholders of record as of the close of business on March 29, 2023. The company offers consulting services in regulatory compliance to various industries, including pharmaceuticals and biotechnology, mainly in Puerto Rico, the United States, Europe, and Latin America. The announcement reflects the company's commitment to returning value to its shareholders.
Pharma-Bio Serv (OTCQB:PBSV), a consulting firm in regulatory compliance, announced its partnership with ACP Capital Markets LLC for investment banking and M&A advisory services. This collaboration is aimed at strategically growing the company through potential acquisitions and enhancing shareholder value. CEO Victor Sanchez expressed optimism about working with ACP, highlighting their M&A expertise. Pharma-Bio Serv's services span across the pharmaceutical and biotechnology sectors, serving markets in Puerto Rico, the U.S., Europe, and Latin America. The company emphasizes regulatory compliance consulting, supported by a skilled global team.
FAQ
What is the current stock price of PHARM-BIO SERV (PBSV)?
What is the market cap of PHARM-BIO SERV (PBSV)?
When was PHARM-BIO SERV INC founded?
What services does PHARM-BIO SERV INC offer?
In which locations does PHARM-BIO SERV INC operate?
What are the divisions created by PHARM-BIO SERV INC to support clients?
What industries does PHARM-BIO SERV INC cater to?
What is the core business of PHARM-BIO SERV INC?
What is the mission of PHARM-BIO SERV INC?
